Madrid, Spain

Carlos Miguel Sanchez Sanchez

This inventor holds 1 USPTO granted patent. Top assignee: Cyanamid Iberica, S.a.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Miguel Sanchez Sanchez. Retrieved from https://idiyas.com/inventor/carlos-miguel-sanchez-sanchez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Carlos Miguel Sanchez Sanchez

Introduction

Carlos Miguel Sanchez Sanchez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of vaccine development through his innovative research and patents. His work focuses on the use of recombinant defective viral genomes to enhance immune responses against infectious agents.

Latest Patents

Sanchez Sanchez holds a patent for "Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines." This patent describes vectors that comprise a recombinant defective viral genome expressing at least one antigen suitable for inducing systemic and secretory immune responses. The vectors are designed to be used in the formulation of mono- and polyvalent vaccines, particularly for various animal species, including pigs, dogs, and cats.

Career Highlights

Throughout his career, Sanchez Sanchez has been associated with Cyanamid Iberica, S.A., where he has contributed to advancements in vaccine technology. His expertise in recombinant viral genomes has positioned him as a key figure in the development of innovative solutions for infectious diseases.

Collaborations

Sanchez Sanchez has collaborated with esteemed colleagues such as Luis Enjuanes Sanchez and Juan Plana Duran. These partnerships have furthered his research and expanded the impact of his work in the scientific community.

Conclusion

Carlos Miguel Sanchez Sanchez is a pioneering inventor whose work in vaccine development has the potential to significantly improve animal health. His innovative approach to using recombinant defective viral genomes showcases the importance of research in combating infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…